Primary Endpoints of Overall ITT
SE
Analysis of the 6MWT at the end of treatment showed the least squares mean (LS) (SE) of change from baseline in distance walked at week 24 was 14.1 (±5.7) meters for participants receiving elamipretide and 17.3 (±5.7) meters for participants receiving placebo, a −3.2-meter difference between the 2 groups (95% CI −18.7 to 12.3; 